Atterocor Inc
Atterocor Inc, based in Ann Arbor, MI, is dedicated to developing innovative, targeted, and immune-mediated cancer therapies, focusing on first-in-class oral drug therapeutics that offer broad potential benefits for cancer patients. The company emphasizes thoughtful exploration of both new and validated pathways to discover and develop novel therapeutics.
Recently, Atterocor has been active in the clinical research space, with updates on their drug candidates and participation in significant healthcare conferences. They have also received Orphan Drug Designation from the FDA for their treatment targeting patients with FAP, underscoring their commitment to advancing cancer treatment options.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
